These findings align with the known phenotype spectrum of PCDH19-related DEE, in which heterozygous females exhibit early-onset, drug-resistant seizures, neurodevelopmental delay, and systemic features, while male carriers are usually unaffected [36]. The gene discussed is PCDH19; the disease is Neurodevelopmental delay.